Janus Dendrimers to Assess the Anti-HCV Activity of Molecules in Cell-Assays
Janus Dendrimers to Assess the Anti-HCV Activity of Molecules in Cell-Assays
About this item
Full title
Author / Creator
Publisher
MDPI
Journal title
Language
English
Formats
Publication information
Publisher
MDPI
Subjects
More information
Scope and Contents
Contents
The use of nanocarriers has been revealed as a valid strategy to facilitate drug bioavailability, and this allows for expanding the drug libraries for the treatment of certain diseases such as viral diseases. In the case of Hepatitis C, the compounds iopanoic acid and 3,3′,5-triiodothyroacetic acid (or tiratricol) were identified in a primary scree...
Alternative Titles
Full title
Janus Dendrimers to Assess the Anti-HCV Activity of Molecules in Cell-Assays
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_2132957aa4b94befb72330b597c47d4f
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2132957aa4b94befb72330b597c47d4f
Other Identifiers
ISSN
1999-4923
E-ISSN
1999-4923
DOI
10.3390/pharmaceutics12111062
